← Back to Markets

SLXN

Silexion Therapeutics Corp · NASDAQ NMS - GLOBAL MARKET · Biotechnology

$1.12$-0.03 (-2.61%)

Prices delayed up to 5 minutes

AC Intelligence

AC Intelligence

AC Intelligence for SLXN is being prepared.

Key Stats

Key Stats

Open

$1.15

Day High

$1.19

Day Low

$1.11

Prev Close

$1.15

Volume

0

Avg Volume

120.4K

Day Change

$-0.03

Change %

-2.61%

Fundamentals

Fundamentals

P/B

2.31

EPS (TTM)

$-12.44

Market Cap

$4M

52-Wk Range

$1.07 — $22.36

Earnings History

Insider Activity

Who Owns This Stock

Who Owns SLXN

Tactical / Macro66.6%1 holder
Other24.1%4 holders
Dealer / Bank9.2%1 holder

Based on Q4 2025 13F filings + AC behavioral model

6 institutional holders

Top Holders

1.Citadel Advisors
$23.4B
2.MONTAG A & ASSOCIATES INC
0.0%$5.8B
3.UBS Group AG
+135.3%$2.6B
4.SBI Securities Co., Ltd.
0.0%$2.0B
5.Pflug Koory, LLC
0.0%$639M
6.UBS Group AG
-45.7%$609M
7.JONES FINANCIAL COMPANIES LLLP
$50M

Institutional Pressure

Market Regime:Strong Risk-Off (-0.62)
SELLINGBUYING
Heavy Selling Pressure
Tactical / Macro(66.6%)
Reducing rapidly
Other(24.1%)
Dealer / Bank(9.2%)
Facilitating

Updated daily · Based on Q4 2025 filings + AC behavioral model

Sentiment Signals

Sentiment Signals

Insider ActivityNo insider transactions in last 90 daysSEC Form 4
↑↑Analyst Consensus7 buy, 1 hold, 0 sellFinnhub
↑↑Inst. Flows3 increased/new, 1 decreased/exited (13F)AC 13F Analysis

Sources: SEC Form 4, Finnhub, AC 13F Analysis

On AcidCapitalist

On AcidCapitalist

No recent mentions of SLXN on AcidCapitalist.

Data provided by Finnhub. Prices delayed up to 5 minutes.